CLSK - GNW IIPR among premarket losers June, 30 2020 08:15 AM CleanSpark Inc. OncoCyte (NYSEMKT:OCX) -46% following unsuccessful results from a clinical validation study of DetermaDx.More news on: OncoCyte Corporation, Zynerba Pharmaceuticals, Inc., Liquidia Technologies, Inc., Stocks on the move, , Read more ...